These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37700273)

  • 1. Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma.
    Jia Y; Liu R; Shi L; Feng Y; Zhang L; Guo N; He A; Kong G
    BMC Cancer; 2023 Sep; 23(1):859. PubMed ID: 37700273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
    Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
    Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk score constructed with neutrophil extracellular traps-related genes predicts prognosis and immune microenvironment in multiple myeloma.
    Gao G; Liu R; Wu D; Gao D; Lv Y; Xu X; Fu B; Lin Z; Wang T; He A; Bai J
    Front Oncol; 2024; 14():1365460. PubMed ID: 38919521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma.
    Gao D; Liu R; Lv Y; Feng Y; Hong F; Xu X; Hu J; He A; Yang Y
    Front Oncol; 2023; 13():999688. PubMed ID: 36845727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia.
    Hua J; Ding T; Shao Y
    Front Immunol; 2022; 13():1040661. PubMed ID: 36591215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L; Wang L; He P
    Front Genet; 2022; 13():1064432. PubMed ID: 36568383
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
    Dai K; Liu C; Guan G; Cai J; Wu L
    BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma.
    Liu R; Shen Y; Hu J; Wang X; Wu D; Zhai M; Bai J; He A
    Front Oncol; 2021; 11():731957. PubMed ID: 34804925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
    Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C
    Front Oncol; 2021; 11():626961. PubMed ID: 33747944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Necroptosis-Related Signature Can Predict Prognosis and Chemotherapy Sensitivity in Multiple Myeloma.
    Jiang JY; Yao FY; Liu J; Wang XL; Huang B; Zhong FM; Wang XZ
    Technol Cancer Res Treat; 2024; 23():15330338241232554. PubMed ID: 38361483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.